V
Market Data
$7.45−$0.44 (−5.58%)
VNDA · Last trade
Prev Close
$7.89
Range (29d)
$6.65 – $9.56
Recent Filings
- 8-K144.3 KBVanda Pharmaceuticals Inc.Apr 2, 4:30 PM ET·0001628280-26-023222
- 8-K146.3 KBVanda Pharmaceuticals Inc.Mar 10, 4:47 PM ET·0001628280-26-016516
- 8-K273.8 KBVanda Pharmaceuticals Inc.Feb 23, 7:00 AM ET·0001628280-26-010376
- 8-K222.7 KBVanda Pharmaceuticals Inc.Feb 19, 4:31 PM ET·0001628280-26-009805
- 10-K12.4 MBVanda Pharmaceuticals Inc.Feb 12, 7:04 AM ET·0001628280-26-007460
- 8-K391.6 KBVanda Pharmaceuticals Inc.Feb 11, 4:05 PM ET·0001628280-26-007256
- 8-K239.0 KBVanda Pharmaceuticals Inc.Jan 8, 7:09 AM ET·0001628280-26-001273
- 8-K251.9 KBVanda Pharmaceuticals Inc.Dec 30, 6:45 PM ET·0001628280-25-059155
- 8-K232.2 KBVanda Pharmaceuticals Inc.Dec 4, 4:39 PM ET·0001628280-25-055393
- 8-K233.0 KBVanda Pharmaceuticals Inc.Nov 28, 7:06 AM ET·0001628280-25-054225
Insiders
10- Baroldi PaoloSVP & Chief Medical Officer
- BATE KENNETHDirector
- Birznieks GuntherSVP, Business Development
- BLAIR JAMES C10% Owner
- CARE CAPITAL II LLC10% Owner
- CARE CAPITAL INVESTMENTS II LP10% Owner
- Chrousos PhaedraDirector
- Clark William DSr. VP, Chief Business Officer
- COLA MICHAEL FDirector
- DEERFIELD MANAGEMENT COMPANY, L.P.10% Owner, Possible Member of 10% Group
Tickers
Addresses
business
2200 PENNSYLVANIA AVE NW SUITE 300E
WASHINGTON, DC, 20037
mailing
2200 PENNSYLVANIA AVE NW SUITE 300E
WASHINGTON, DC, 20037